Permeation enhancing compositions for anticholinergic agents

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S818000, C514S821000

Reexamination Certificate

active

07425340

ABSTRACT:
A transdermal or topical composition including anticholinergic agents, such as oxybutynin, a urea-containing compound and a carrier system. A method is disclosed for treating a subject for urinary incontinence while reducing the incidences of peak concentrations of drug and undesirable side effects.

REFERENCES:
patent: 4082881 (1978-04-01), Chen et al.
patent: 4315925 (1982-02-01), Hussain et al.
patent: 4383993 (1983-05-01), Hussain et al.
patent: 4390532 (1983-06-01), Stuttgen et al.
patent: 4537776 (1985-08-01), Cooper
patent: 4597961 (1986-07-01), Etscorn
patent: 4704406 (1987-11-01), Stanislaus et al.
patent: 4764381 (1988-08-01), Bodor et al.
patent: 4832953 (1989-05-01), Campbell et al.
patent: 4863970 (1989-09-01), Patel et al.
patent: 4883660 (1989-11-01), Blackman et al.
patent: 4952560 (1990-08-01), Kigasawa et al.
patent: 4956171 (1990-09-01), Chang
patent: 4973468 (1990-11-01), Chiang et al.
patent: 5041439 (1991-08-01), Kasting et al.
patent: 5053227 (1991-10-01), Chiang et al.
patent: 5059426 (1991-10-01), Chiang et al.
patent: 5071657 (1991-12-01), Oloff et al.
patent: 5128138 (1992-07-01), Blank
patent: 5164190 (1992-11-01), Patel et al.
patent: 5178879 (1993-01-01), Adekunle et al.
patent: 5230896 (1993-07-01), Yeh et al.
patent: 5232703 (1993-08-01), Blank
patent: 5238933 (1993-08-01), Catz et al.
patent: 5278176 (1994-01-01), Lin
patent: 5352457 (1994-10-01), Jenkins
patent: 5371005 (1994-12-01), Fujishiro et al.
patent: 5453279 (1995-09-01), Lee et al.
patent: 5527832 (1996-06-01), Chi et al.
patent: 5532278 (1996-07-01), Aberg et al.
patent: 5580574 (1996-12-01), Behl et al.
patent: 5601839 (1997-02-01), Quan et al.
patent: 5602017 (1997-02-01), Fujishiro et al.
patent: 5603947 (1997-02-01), Wong et al.
patent: 5629021 (1997-05-01), Wright
patent: 5633008 (1997-05-01), Osborne et al.
patent: 5658587 (1997-08-01), Santus et al.
patent: 5660839 (1997-08-01), Allec et al.
patent: 5662890 (1997-09-01), Punto et al.
patent: 5665560 (1997-09-01), Fujishiro et al.
patent: 5677346 (1997-10-01), Aberg et al.
patent: 5716638 (1998-02-01), Touitou
patent: 5719197 (1998-02-01), Kanios et al.
patent: 5731303 (1998-03-01), Hsieh
patent: 5736577 (1998-04-01), Aberg et al.
patent: 5783207 (1998-07-01), Stanley et al.
patent: 5785991 (1998-07-01), Burkoth et al.
patent: 5798242 (1998-08-01), Fujishiro et al.
patent: 5814659 (1998-09-01), Elden
patent: 5831035 (1998-11-01), Timms
patent: 5834010 (1998-11-01), Quan et al.
patent: 5855905 (1999-01-01), Oettel et al.
patent: 5855920 (1999-01-01), Chein
patent: 5891462 (1999-04-01), Carrara
patent: 5900250 (1999-05-01), Lee et al.
patent: 5904931 (1999-05-01), Lipp et al.
patent: 5922349 (1999-07-01), Elliesen et al.
patent: 5932243 (1999-08-01), Fricker et al.
patent: 5935604 (1999-08-01), Illum
patent: 5968919 (1999-10-01), Samour et al.
patent: 6008192 (1999-12-01), Al-Razzak et al.
patent: 6034079 (2000-03-01), Sandberg et al.
patent: 6060077 (2000-05-01), Meignant
patent: 6096733 (2000-08-01), Lubkin
patent: 6123961 (2000-09-01), Aberg
patent: 6124355 (2000-09-01), Guittard et al.
patent: 6153216 (2000-11-01), Cordes et al.
patent: 6165497 (2000-12-01), Osborne et al.
patent: 6166044 (2000-12-01), Sandborn et al.
patent: 6180803 (2001-01-01), Piasco et al.
patent: 6267985 (2001-07-01), Chen et al.
patent: 6284234 (2001-09-01), Niemiec et al.
patent: 6299900 (2001-10-01), Reed et al.
patent: 6309843 (2001-10-01), Timms
patent: 6319913 (2001-11-01), Mak et al.
patent: 6383471 (2002-05-01), Chen et al.
patent: 6417205 (2002-07-01), Cooke et al.
patent: 6426078 (2002-07-01), Bauer et al.
patent: 6432446 (2002-08-01), Aberg
patent: 6440454 (2002-08-01), Santoro et al.
patent: 6444234 (2002-09-01), Kirby et al.
patent: 6465005 (2002-10-01), Biali et al.
patent: 6476012 (2002-11-01), Hochberg
patent: 6479076 (2002-11-01), Blank
patent: 6497897 (2002-12-01), Hidaka et al.
patent: 6503894 (2003-01-01), Dudley et al.
patent: 6545046 (2003-04-01), Sherratt et al.
patent: 6586000 (2003-07-01), Luo et al.
patent: 6596740 (2003-07-01), Jones
patent: 6743441 (2004-06-01), Sanders et al.
patent: 6818226 (2004-11-01), Reed et al.
patent: 6828336 (2004-12-01), Walling
patent: 6929801 (2005-08-01), Klose et al.
patent: 2001/0023261 (2001-09-01), Ryoo
patent: 2001/0031787 (2001-10-01), Hsu et al.
patent: 2001/0033870 (2001-10-01), Luo et al.
patent: 2001/0038855 (2001-11-01), Desjardin et al.
patent: 2002/0147236 (2002-10-01), Sanders et al.
patent: 2002/0183296 (2002-12-01), Dudley et al.
patent: 2003/0022877 (2003-01-01), Dudley
patent: 2003/0050292 (2003-03-01), Dudley et al.
patent: 2003/0095926 (2003-05-01), Dugger, III
patent: 2003/0139384 (2003-07-01), Dudley
patent: 2003/0143278 (2003-07-01), DiPiano et al.
patent: 2003/0147926 (2003-08-01), Ebert et al.
patent: 2003/0175329 (2003-09-01), Azarnoff et al.
patent: 2003/0181430 (2003-09-01), Gray et al.
patent: 2003/0199426 (2003-10-01), Carrara et al.
patent: 2003/0222105 (2003-12-01), Lee et al.
patent: 2003/0232072 (2003-12-01), Dudley et al.
patent: 2004/0002482 (2004-01-01), Dudley et al.
patent: 2004/0139990 (2004-07-01), Wachter et al.
patent: 2004/0198706 (2004-10-01), Carrara et al.
patent: 2004/0213744 (2004-10-01), Lulla et al.
patent: 2004/0219197 (2004-11-01), Carrara et al.
patent: 0 249 397 (1987-12-01), None
patent: 0 250 125 (1987-12-01), None
patent: 0 261 429 (1988-03-01), None
patent: 0 267 617 (1988-05-01), None
patent: 0 271 983 (1988-06-01), None
patent: 0 279 977 (1988-08-01), None
patent: 0 325 613 (1989-06-01), None
patent: 0 367 431 (1990-05-01), None
patent: 0 409 383 (1991-01-01), None
patent: 0 435 200 (1991-07-01), None
patent: 0 491 803 (1992-07-01), None
patent: 0 526 561 (1993-02-01), None
patent: 0 643 963 (1995-03-01), None
patent: 0 655 900 (1995-06-01), None
patent: 0 672 422 (1995-09-01), None
patent: 0 719 538 (1996-07-01), None
patent: 0 785 211 (1997-07-01), None
patent: 0 785 212 (1997-07-01), None
patent: 0 802 782 (1997-10-01), None
patent: 0 804 926 (1997-11-01), None
patent: 0 811 381 (1997-12-01), None
patent: 0 814 776 (1998-01-01), None
patent: 0 859 793 (1998-08-01), None
patent: 0 868 187 (1998-10-01), None
patent: 1 089 722 (2001-04-01), None
patent: 1 323 430 (2003-07-01), None
patent: 1 323 431 (2003-07-01), None
patent: 1 325 752 (2003-07-01), None
patent: 2 518 879 (1983-07-01), None
patent: 2 776 191 (1999-09-01), None
patent: 9-176049 (1997-07-01), None
patent: WO 90/11064 (1990-10-01), None
patent: WO 92/08730 (1992-05-01), None
patent: WO 94/06437 (1994-03-01), None
patent: WO 95/18603 (1995-07-01), None
patent: WO 95/29678 (1995-11-01), None
patent: WO 97/03676 (1997-02-01), None
patent: WO 97/29735 (1997-08-01), None
patent: WO 97/34607 (1997-09-01), None
patent: WO 98/17316 (1998-04-01), None
patent: WO 98/37879 (1998-09-01), None
patent: WO 99/20257 (1999-04-01), None
patent: WO 99/24041 (1999-05-01), None
patent: WO 99/48477 (1999-09-01), None
patent: WO 01/80796 (2001-11-01), None
patent: WO 02/11768 (2002-02-01), None
patent: WO 02/17967 (2002-03-01), None
patent: WO 02/22132 (2002-03-01), None
US 6,214,374, 04/2001, Schmirier et al. (withdrawn)
English Abstract NLM2807923 XP-002337932, “Promoting Penetration Of Locally Applied Substances By Urea”.
David W. Osborne et al., XP 002337808, “Skin Penetration Enhancers Cited in the Technical Literature”.
A.C. Williams et al., XP 000645464,“Urea Analogues In Propylene Glycol As Penetration Enhancers In Human Skin”, International Journal of Pharmaceutics, vol. 36, pp. 43-50 (1989).
Koichi Takahashi et al., “Effect of Vehicles on Diclofenac Permeation across Excised Rat Skin”, Biol. Pharm. Bull., vol. 18, No. 4, pp. 571-575 (1995).
Budavari et al., The Merk Index, 1996, Merck Research Laboratories, 12th Edition, pp. 253 and 269.
Kotiyan et al., “Eudragits:Role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol,” European Journal of Pharmaceutics and Biopharmaceutics 52: 173-180 (2001).
Lipp, “Selection and use of crystallization inhibitors for matrix-type transdermal dr

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Permeation enhancing compositions for anticholinergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Permeation enhancing compositions for anticholinergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Permeation enhancing compositions for anticholinergic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3979100

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.